Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Arrhythmias

Free Subscription Articles published in Cardiovasc Res Retrieve available abstracts of 63 articles: HTML format

Single Articles

June 2026
1. BRAUN AMT, Lang A, Wagner JUG
   Cell-specific vulnerabilities and adaptations in atrial aging.
   Cardiovasc Res. 2026;122:973-983.
   PubMed     Abstract available
   
   
   May 2026
2. REDONDO-RODRIGUEZ A, Quintanilla JG, Macias A, Lee P, et al
   Ventricular fibrillation dynamics reveal regional asymmetry in resilience to cardiac arrest and predict clinical outcome.
   Cardiovasc Res. 2026 May 28:cvag101. doi: 10.1093.
   PubMed     Abstract available
   
   
   
3. CUMBERLAND MJ, Dasi A, Sontayananon N, Marcus A, et al
   A titin truncating variant linked to atrial fibrillation increases atrial profibrotic signalling and cholinergic sensitivity.
   Cardiovasc Res. 2026 May 27:cvag112. doi: 10.1093.
   PubMed     Abstract available
   
   
   
4. KHUDIAKOV A, Mura M, Giannetti F, Leonov V, et al
   Machine learning-guided risk stratification for Long QT Syndrome genetic variants with hiPSC-derived cardiomyocytes.
   Cardiovasc Res. 2026 May 14:cvag105. doi: 10.1093.
   PubMed     Abstract available
   
   
   
5. BARALLOBRE-BARREIRO J, Mayr M
   Proteomic insights into bi-atrial remodelling in persistent atrial fibrillation.
   Cardiovasc Res. 2026 May 9:cvag104. doi: 10.1093.
   PubMed    
   
   
   April 2026
6. LIUTKUTE A, Berrandou TE, Kestel S, Schnelle M, et al
   Mass spectrometric proteome profiling using a deep spectral library reveals homogenization of right and left atrial proteomes in persistent atrial fibrillation patients.
   Cardiovasc Res. 2026 Apr 2:cvag076. doi: 10.1093.
   PubMed     Abstract available
   
   
   March 2026
7. DING JF, Liu ZY, Tu B, Gao L, et al
   RUNX1 N6-methyladenosine methylation enhances cytoskeleton remodelling and boosts cardiac fibrosis.
   Cardiovasc Res. 2026;122:363-378.
   PubMed     Abstract available
   
   
   
8. SOCUELLAMOS PG, Macias A, de Benito-Bueno A, Cruz FM, et al
   Lgi3-4 proteins modulate the KV1.5 channelosome and are potential therapeutic targets for atrial fibrillation.
   Cardiovasc Res. 2026 Mar 19:cvag049. doi: 10.1093.
   PubMed     Abstract available
   
   
   February 2026
9. ZHANG YS, Liu ZY, Lin LC, Tu B, et al
   Epigenetic blockade of SOD2 boosts mitochondria ROS and cytoskeleton remodelling in cardiac fibrosis.
   Cardiovasc Res. 2026;122:66-80.
   PubMed     Abstract available
   
   
   
10. TJONG FVY, Van Gelder IC
    Atrial fibrillation screening: time for precision, not just detection.
    Cardiovasc Res. 2026;122:1-3.
    PubMed    
    
    
    
11. HEIJMAN J
    Elucidating the mechanisms of atrial fibrillation recurrence: opportunities and challenges for longitudinal digital twins.
    Cardiovasc Res. 2026 Feb 6:cvag027. doi: 10.1093.
    PubMed    
    
    
    January 2026
12. YAMAMOTO C, Sakata K, Ali SY, Loeffler S, et al
    Arrhythmogenic substrates in atrial fibrillation and the role of ablation lesions: A longitudinal biatrial digital twin study.
    Cardiovasc Res. 2026 Jan 19:cvag016. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2025
13. XIONG H, Guo D, Zhou Z, Xiang L, et al
    Coupling of USP10 de-ubiquitination and chaperone-mediated autophagy causes cardiac sodium channel degradation and cardiac arrhythmias.
    Cardiovasc Res. 2025;121:2520-2533.
    PubMed     Abstract available
    
    
    
14. LIU Y, Shen P, Li G, Wang T, et al
    miR-4324-containing extracellular vesicles released in pericardial drainage fluid facilitate postoperative atrial fibrillation.
    Cardiovasc Res. 2025 Dec 5:cvaf239. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2025
15. BRUNS F, Fender AC, Poppenborg T, Dudley SC, et al
    Type 1 diabetes mellitus and atrial fibrillation - clinical relationships, mechanistic insights and therapeutic implications.
    Cardiovasc Res. 2025 Nov 26:cvaf252. doi: 10.1093.
    PubMed     Abstract available
    
    
    
16. JANI NR, van Weperen VYH, Ayagama T, Hoang JD, et al
    Sympathovagal crosstalk: Y2-receptor blockade enhances vagal effects which in turn reduce NPY levels via muscarinic receptor activation.
    Cardiovasc Res. 2025;121:2189-2203.
    PubMed     Abstract available
    
    
    September 2025
17. ISHIKAWA T, Kimoto H, Seki A, Shirai M, et al
    Phenotypic spectrum of cardiac conduction disturbance and cardiomyopathy linked to titin canonical splice-site variants.
    Cardiovasc Res. 2025;121:1712-1721.
    PubMed     Abstract available
    
    
    August 2025
18. HADAYA J, Boukens BJD, Janse MJ, Cha S, et al
    Right stellate ganglion stimulation modulates arrhythmogenesis in acute left lateral ventricular ischaemia.
    Cardiovasc Res. 2025;121:1385-1391.
    PubMed     Abstract available
    
    
    July 2025
19. GIAMMARINO L, Matas L, Alerni N, Horvath A, et al
    Sex and sex hormonal regulation of the atrial inward rectifier potassium current (IK1): insights into potential pro-arrhythmic mechanisms.
    Cardiovasc Res. 2025;121:1215-1227.
    PubMed     Abstract available
    
    
    June 2025
20. MASON FE, Liutkute A, Voigt N
    Testosterone and atrial fibrillation: does the dose make the poison?
    Cardiovasc Res. 2025 Jun 21:cvaf113. doi: 10.1093.
    PubMed    
    
    
    May 2025
21. RUBERTO F, Foo R
    Atrial fibrillation: a measure from one circular RNA.
    Cardiovasc Res. 2025 May 19:cvaf083. doi: 10.1093.
    PubMed    
    
    
    
22. GAO Y, Dong Y, Jiang N, Zhang H, et al
    Atrial remodelling and atrial fibrillation self-sustaining: the role of circulating circDGCR8.
    Cardiovasc Res. 2025 May 8:cvaf060. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2025
23. KEEFE JA, Wang J, Song J, Ni L, et al
    Immune cells and arrhythmias.
    Cardiovasc Res. 2025;121:382-395.
    PubMed     Abstract available
    
    
    
24. MUNOZ-MARTIN N, Simon-Chica A, Diaz-Diaz C, Cadenas V, et al
    Meis transcription factors regulate cardiac conduction system development and adult function.
    Cardiovasc Res. 2025;121:311-323.
    PubMed     Abstract available
    
    
    
25. MIRA HERNANDEZ J, Shen EY, Ko CY, Hourani Z, et al
    Differential sex-dependent susceptibility to diastolic dysfunction and arrhythmia in cardiomyocytes from obese diabetic heart failure with preserved ejection fraction model.
    Cardiovasc Res. 2025;121:254-266.
    PubMed     Abstract available
    
    
    
26. LIN S, Schwartz TH, Pitt GS
    Sudden unexpected death in epilepsy: respiratory vs. cardiac contributions.
    Cardiovasc Res. 2025;120:2385-2394.
    PubMed     Abstract available
    
    
    January 2025
27. LIU W, Liu J, Wang G, Cheng W, et al
    Downregulation of HDAC2 attenuates ventricular arrhythmias in a mouse model of cardiac hypertrophy through upregulation of KCHIP2 expression.
    Cardiovasc Res. 2025 Jan 28:cvaf008. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2024
28. REYAT JS, Sommerfeld LC, O'Reilly M, Roth Cardoso V, et al
    PITX2 deficiency leads to atrial mitochondrial dysfunction.
    Cardiovasc Res. 2024;120:1907-1923.
    PubMed     Abstract available
    
    
    November 2024
29. BODI I, Mettke L, Michaelides K, Hornyik T, et al
    Beneficial normalization of cardiac repolarization by carnitine in transgenic short QT syndrome type 1 rabbit models.
    Cardiovasc Res. 2024;120:1550-1561.
    PubMed     Abstract available
    
    
    October 2024
30. LI X, Bao Y, Zhang N, Lin C, et al
    Senescent CD8+ T cells: a novel risk factor in atrial fibrillation.
    Cardiovasc Res. 2024 Oct 9:cvae222. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2024
31. HU W, Tu H, Wadman MC, Li YL, et al
    Renal denervation achieves its antiarrhythmic effect through attenuating macrophage activation and neuroinflammation in stellate ganglia in chronic heart failure.
    Cardiovasc Res. 2024 Sep 25:cvae196. doi: 10.1093.
    PubMed     Abstract available
    
    
    
32. LI N, Cui L, Korantzopoulos P, Zhang N, et al
    Association between cumulative uric acid exposure and the risk of incident cardiac conduction block.
    Cardiovasc Res. 2024;120:1104-1106.
    PubMed    
    
    
    
33. FAKIH W, Mroueh A, Gong DS, Kikuchi S, et al
    Activated factor X stimulates atrial endothelial cells and tissues to promote remodelling responses through AT1R/NADPH oxidases/SGLT1/2.
    Cardiovasc Res. 2024;120:1138-1154.
    PubMed     Abstract available
    
    
    July 2024
34. COLEMAN JA, Doste R, Ashkir Z, Coppini R, et al
    Mechanisms of ischaemia-induced arrhythmias in hypertrophic cardiomyopathy: a large-scale computational study.
    Cardiovasc Res. 2024;120:914-926.
    PubMed     Abstract available
    
    
    May 2024
35. LIUTKUTE A, Prosser BL, Voigt N
    Microtubules: highway to ... arrhythmia?
    Cardiovasc Res. 2024;120:671-672.
    PubMed    
    
    
    
36. ODENING KE
    Interactions between KCNQ1 and KCNH2 may modulate the long QT type 1 phenotype.
    Cardiovasc Res. 2024;120:673-674.
    PubMed    
    
    
    
37. WADA Y, Wang L, Hall LD, Yang T, et al
    The electrophysiologic effects of KCNQ1 extend beyond expression of IKs: evidence from genetic and pharmacologic block.
    Cardiovasc Res. 2024;120:735-744.
    PubMed     Abstract available
    
    
    
38. PAVLAKI N, Froese A, Li W, De Jong KA, et al
    Gene therapy with phosphodiesterases 2A and 4B ameliorates heart failure and arrhythmias by improving subcellular cAMP compartmentation.
    Cardiovasc Res. 2024 May 22:cvae094. doi: 10.1093.
    PubMed     Abstract available
    
    
    
39. KEEFE JA, Zhao S, Wehrens XHT
    A mechanistic LNK between inflammation and atrial fibrillation?
    Cardiovasc Res. 2024 May 7:cvae083. doi: 10.1093.
    PubMed    
    
    
    April 2024
40. MEHDIZADEH M, Naud P, Abu-Taha IH, Hiram R, et al
    The role of cellular senescence in profibrillatory atrial remodelling associated with cardiac pathology.
    Cardiovasc Res. 2024;120:506-518.
    PubMed     Abstract available
    
    
    
41. KAHNERT K, Soattin L, Mills RW, Wilson C, et al
    Proteomics couples electrical remodelling to inflammation in a murine model of heart failure with sinus node dysfunction.
    Cardiovasc Res. 2024 Apr 25:cvae054. doi: 10.1093.
    PubMed     Abstract available
    
    
    
42. FABRITZ L, Chua W, Cardoso VR, Al-Taie C, et al
    Blood-based cardiometabolic phenotypes in atrial fibrillation and their associated risk: EAST-AFNET 4 biomolecule study.
    Cardiovasc Res. 2024 Apr 13:cvae067. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2024
43. DE COSTER T, Teplenin AS, Feola I, Bart CI, et al
    'Trapped re-entry' as source of acute focal atrial arrhythmias.
    Cardiovasc Res. 2024;120:249-261.
    PubMed     Abstract available
    
    
    
44. TONKO JB, Lambiase PD
    The proarrhythmogenic role of autonomics and emerging neuromodulation approaches to prevent sudden death in cardiac ion channelopathies.
    Cardiovasc Res. 2024;120:114-131.
    PubMed     Abstract available
    
    
    February 2024
45. KIZER JR
    The elusive quest for causality in adiponectin's bimodal relationship with cardiovascular disease: Mendelian randomization meets Janus.
    Cardiovasc Res. 2024;120:3-5.
    PubMed    
    
    
    
46. HARDING D, Fanti S, Marelli-Berg F
    Tumour necrosis factor-alpha in cardiac inflammation: friend or foe?
    Cardiovasc Res. 2024;120:1-2.
    PubMed    
    
    
    
47. HEIJMAN J, Madreiter-Sokolowski CT
    Is ageing a modifiable risk factor for atrial fibrillation?
    Cardiovasc Res. 2024 Feb 26:cvae040. doi: 10.1093.
    PubMed    
    
    
    
48. FABRITZ L, Lemoine MD
    Atrial fibrillation in the young: consider heritable conditions like short QT syndrome.
    Cardiovasc Res. 2024 Feb 22:cvae041. doi: 10.1093.
    PubMed    
    
    
    
49. VELASCO JJ, Akar FG
    A new year's resolution to resolve atrial fibrillation: Resolvin D1 emerges as a powerful target against post-MI atrial remodeling.
    Cardiovasc Res. 2024 Feb 22:cvae039. doi: 10.1093.
    PubMed    
    
    
    
50. MURPHY MB, Yang Z, Subati T, Farber-Eger E, et al
    LNK/SH2B3 loss of function increases susceptibility to murine and human atrial fibrillation.
    Cardiovasc Res. 2024 Feb 20:cvae036. doi: 10.1093.
    PubMed     Abstract available
    
    
    
51. ROGERS AJ, Narayan SM
    Latent drivers for atrial fibrillation and specific patterns of localized fibrosis.
    Cardiovasc Res. 2024 Feb 20:cvae032. doi: 10.1093.
    PubMed    
    
    
    January 2024
52. NGUYEN MN, Hooper C, Stefanini M, Vrellaku B, et al
    Why is early-onset atrial fibrillation uncommon in patients with Duchenne Muscular Dystrophy? Insights from the mdx mouse.
    Cardiovasc Res. 2024 Jan 25:cvae022. doi: 10.1093.
    PubMed     Abstract available
    
    
    
53. MORENO-MANUEL AI, Macias A, Cruz FM, Gutierrez LK, et al
    The Kir2.1E299V mutation increases atrial fibrillation vulnerability while protecting the ventricles against arrhythmias in a mouse model of Short QT Syndrome type 3.
    Cardiovasc Res. 2024 Jan 23:cvae019. doi: 10.1093.
    PubMed     Abstract available
    
    
    
54. SHI Q, Malik H, Crawford RM, Streeter J, et al
    Cardiac MAO-A inhibition protects against catecholamine-induced ventricular arrhythmias via enhanced diastolic calcium control.
    Cardiovasc Res. 2024 Jan 10:cvae012. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2023
55. DOREY TW, McRae MD, Belke DD, Rose RA, et al
    PDE4D mediates impaired beta-adrenergic receptor signalling in the sinoatrial node in mice with hypertensive heart disease.
    Cardiovasc Res. 2023;119:2697-2711.
    PubMed     Abstract available
    
    
    
56. OLCUM M, Fan S, Rouhi L, Cheedipudi S, et al
    Genetic inactivation of beta-catenin is salubrious, whereas its activation is deleterious in desmoplakin cardiomyopathy.
    Cardiovasc Res. 2023;119:2712-2728.
    PubMed     Abstract available
    
    
    
57. HIRAM R, Xiong F, Naud P, Xiao J, et al
    An inflammation resolution-promoting intervention prevents atrial fibrillation due to left-ventricular dysfunction.
    Cardiovasc Res. 2023 Dec 13:cvad175. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2023
58. NIELSEN MB, Colak Y, Benn M, Mason A, et al
    Plasma adiponectin levels and risk of heart failure, atrial fibrillation, aortic valve stenosis, and myocardial infarction: large scale observational and Mendelian randomization evidence.
    Cardiovasc Res. 2023 Oct 28:cvad162. doi: 10.1093.
    PubMed     Abstract available
    
    
    
59. NI H, Morotti S, Zhang X, Dobrev D, et al
    Integrative human atrial modelling unravels interactive protein kinase A and Ca2+/calmodulin-dependent protein kinase II signalling as key determinants of atrial arrhythmogenesis.
    Cardiovasc Res. 2023;119:2294-2311.
    PubMed     Abstract available
    
    
    
60. JONES CA, Wallace MJ, Bandaru P, Woodbury ED, et al
    E-cigarettes and arrhythmogenesis: a comprehensive review of pre-clinical studies and their clinical implications.
    Cardiovasc Res. 2023;119:2157-2164.
    PubMed     Abstract available
    
    
    September 2023
61. VENKATESHAPPA R, Hunter DV, Muralidharan P, Nagalingam RS, et al
    Targeted activation of hERG channels rescues electrical instability induced by the hERG R56Q+/- Long QT Syndrome variant.
    Cardiovasc Res. 2023 Sep 21:cvad155. doi: 10.1093.
    PubMed     Abstract available
    
    
    
62. LAKIN R, Polidovitch N, Yang S, Parikh M, et al
    Cardiomyocyte and endothelial cells play distinct roles in the tumor necrosis factor (TNF)-dependent atrial responses and increased atrial fibrillation vulnerability induced by endurance exercise training in mice.
    Cardiovasc Res. 2023 Sep 15:cvad144. doi: 10.1093.
    PubMed     Abstract available
    
    
    
63. SEIBERTZ F, Rubio T, Springer R, Popp F, et al
    Atrial fibrillation-associated electrical remodelling in human induced pluripotent stem cell-derived atrial cardiomyocytes: a novel pathway for antiarrhythmic therapy development.
    Cardiovasc Res. 2023 Sep 7:cvad143. doi: 10.1093.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum